Possible Modulatory Role of ARC Gene Variants in Mood Disorders.
ARC gene
Bipolar disorder
Depressive disorder
Mood disorder
Journal
Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology
ISSN: 1738-1088
Titre abrégé: Clin Psychopharmacol Neurosci
Pays: Korea (South)
ID NLM: 101207332
Informations de publication
Date de publication:
28 Feb 2021
28 Feb 2021
Historique:
received:
20
06
2019
accepted:
29
07
2019
entrez:
28
1
2021
pubmed:
29
1
2021
medline:
29
1
2021
Statut:
ppublish
Résumé
The genetic background of mood disorders is gradually emerging through the use of large multicenter samples but a detailed phenotyping is complementary in elucidating the role of modulating variants. In the present paper we focused on the possible modulatory effects of ARC gene variants on two independent mood disorder samples of European (n = 246 bipolar disorder) and Korean (n = 132 bipolar disorder; n = 242 major depressive disorder [MDD]) ancestry. No result survived Bonferroni correction, however we evidenced promising trend toward possible association between ARC gene variants and mood disorder phenotypes. In particular, we evidenced weak correlations of ARC single nucleotide polymorphisms with depressive symptoms severity (evaluated through Hamilton depression rating scale scores) in the MDD Korean (rs7465272) and European (rs11167152) samples. Additionally rs10110456 was found to be related to Family History, while rs7465272 was related to suicide risk in the Korean sample. Finally, rs7465272 was associated with body mass index in the European sample. Overall, ARC gene variants may have a partial role in modulatory effect on treatment efficacy or phenotypes of mood disorders. Further studies, on larger samples may provide a better understanding on the role of ARC gene variants in the symptom severity and treatment outcomes in patients with mood disorders.
Identifiants
pubmed: 33508787
pii: cpn.2021.19.1.46
doi: 10.9758/cpn.2021.19.1.46
pmc: PMC7851469
doi:
Types de publication
Journal Article
Langues
eng
Pagination
46-52Références
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Clin Psychopharmacol Neurosci. 2019 Aug 31;17(3):364-368
pubmed: 31352702
Semin Cell Dev Biol. 2018 May;77:33-42
pubmed: 28890419
Expert Rev Clin Pharmacol. 2017 Feb;10(2):153-166
pubmed: 27781556
Eur Neuropsychopharmacol. 2012 Jul;22(7):453-68
pubmed: 22464339
Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33
pubmed: 19378696
Psychol Med. 2019 Jan;49(2):351
pubmed: 30334498
Commun Biol. 2018 Oct 8;1:163
pubmed: 30320231
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
Neuropharmacology. 2000 Jan 28;39(3):463-70
pubmed: 10698012
Compr Psychiatry. 2012 Jan;53(1):24-38
pubmed: 21414619
Adv Ther. 2017 Jun;34(6):1482-1497
pubmed: 28508933
Front Neurosci. 2015 Aug 10;9:279
pubmed: 26321903
Neuron. 1995 Feb;14(2):433-45
pubmed: 7857651
Proc Natl Acad Sci U S A. 2010 Oct 19;107(42):18173-8
pubmed: 20921410
Neurochem Int. 2014 Sep;75:76-8
pubmed: 24915645
Bioinformatics. 2005 Jan 15;21(2):263-5
pubmed: 15297300
Nat Genet. 2019 May;51(5):793-803
pubmed: 31043756
J Neurosci Res. 2004 Apr 1;76(1):51-63
pubmed: 15048929
Clin Psychopharmacol Neurosci. 2020 May 31;18(2):231-240
pubmed: 32329304
J Neurosci. 2007 Sep 26;27(39):10445-55
pubmed: 17898216
Adv Ther. 2017 Mar;34(3):713-724
pubmed: 28144920
Curr Psychiatry Rep. 2017 Aug;19(8):43
pubmed: 28608123
Neuroscience. 2004;128(3):597-604
pubmed: 15381288
Psychiatr Pol. 2017 Apr 30;51(2):197-203
pubmed: 28581531
Hum Psychopharmacol. 2018 Nov;33(6):e2682
pubmed: 30426571
Neuropsychobiology. 2016;74(3):159-168
pubmed: 28494468